Ostatní
Návod 
Boston Scientific Corporation
BSX
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
148.2B
Obrat
20B
Zisk
3B
Aktiva
42B
Dluh
12B
ROE
0%
ROA
0%
PE
36
PS
5
Cena 1R
86-110
⌀ Cena
100.59
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
22-04-2026
Poslední dividenda
Profil
Společnost Boston Scientific Corporation vyvíjí, vyrábí a prodává zdravotnické prostředky pro použití v různých intervenčních lékařských oborech po celém světě. Působí ve třech segmentech: MedSurg, Rhythm a Neuro a Kardiovaskulární. Společnost nabízí přístroje pro diagnostiku a léčbu gastrointestinálních a plicních stavů; přístroje pro léčbu různých urologických a pánevních stavů; implantabilní kardioverter a implantabilní defibrilátory pro resynchronizační terapii srdce; kardiostimulátory a implantabilní kardiostimulační kardiostimulátory; a systémy pro vzdálenou péči o pacienty. Poskytuje také lékařské technologie pro diagnostiku a léčbu poruch srdečního rytmu a rychlosti, které zahrnují 3-D kardiální mapování a navigační řešení, ablační katétry, diagnostické katétry, mapovací katétry, intrakardiální ultrazvukové katétry, porodní pouzdra a další příslušenství; systémy stimulátorů míchy pro zvládání chronické bolesti; systémy nepřímé dekomprese a systémy hluboké stimulace mozku. Kromě toho společnost nabízí produkty intervenční kardiologie, včetně koronárních stentových systémů uvolňujících léky používaných při léčbě onemocnění koronárních tepen; perkutánní koronární intervenční přípravky k léčbě aterosklerózy; ultrazvukové katétry řízené intravaskulárním katétrem, zařízení pro udržování frakčního toku a systémy pro použití v koronárních tepnách a srdečních komorách, jakož i v různých periferních cévách; a strukturální terapie srdeční činnosti. Dále poskytuje stenty, balonové katétry, dráty a systémy pro rektomii k léčbě onemocnění tepen; trombektomii a akustické pulzní trombolýze systémy, dráty a stenty k léčbě žilních onemocnění; a periferní embolizační zařízení, radioaktivní mikrosféry, ablační systémy, systémy pro ablaci kryoterapie a mikrokatétry a katétry kanalizace k léčbě rakoviny. Společnost byla založena v roce 1979 a sídlí v Marlborough ve státě Massachusetts.
Sektor
Healthcare
Odvětví
Medical - Devices
Počet zaměstnanců
53000
Založení
1992-05-19
Podobné společnosti
$ 353.94
- $ 2.09
$ 92.21
+ $ 0.01
$ 209.92
- $ 0.03
$ 117.95
- $ 0.89
$ 24.16
- $ 0.28
$ 321.61
+ $ 1.41
$ 125.44
- $ 0.93
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliardách (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 20.08 | 20.07 | 16.75 | 14.24 | 12.68 | 11.89 | 9.91 | 10.74 | 9.82 | 9.05 | 8.39 | 7.48 | 7.38 | 7.14 | 7.25 | 7.62 | 7.81 | |
| Cost of Revenues | 6.22 | 6.22 | 6.48 | 4.35 | 4.00 | 3.76 | 3.51 | 3.18 | 2.88 | 2.66 | 2.50 | 2.24 | 2.32 | 2.31 | 2.50 | 2.66 | 2.60 | |
| Gross Profit | 13.85 | 13.85 | 10.27 | 9.90 | 8.68 | 8.13 | 6.40 | 7.55 | 6.94 | 6.39 | 5.88 | 5.23 | 5.06 | 4.83 | 4.75 | 4.96 | 5.21 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 5.29 | 5.07 | 5.06 | 4.66 | 4.56 | 4.21 | 4.12 | 3.86 | 3.73 | 3.53 | |
| Cost of Revenues | 1.35 | 1.52 | 1.64 | 1.71 | 1.89 | 1.56 | 1.54 | 1.47 | 1.15 | 1.11 | |
| Gross Profit | 3.94 | 3.54 | 3.42 | 2.95 | 2.67 | 2.65 | 2.59 | 2.38 | 2.58 | 2.42 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.00 | 0.00 | 0.00 | 1.41 | 1.32 | 1.20 | 1.14 | 1.17 | 1.11 | 1.00 | 0.92 | 0.88 | 0.82 | 0.86 | 0.89 | 0.90 | 0.94 | |
| Selling General & Admin Expenses | 0.00 | 0.00 | 0.00 | 5.19 | 4.52 | 4.36 | 3.79 | 3.94 | 3.57 | 3.29 | 3.10 | 2.87 | 2.90 | 2.67 | 2.54 | 2.66 | 2.77 | |
| Depreciation & Amortization | 1.00 | 0.00 | 1.27 | 1.20 | 1.15 | 0.74 | 0.79 | 0.56 | 0.60 | 0.57 | 0.55 | 0.50 | 0.44 | 0.41 | 0.40 | 0.42 | 0.51 | |
| Total Operating Expenses | 9.88 | 9.88 | 7.63 | 7.55 | 6.65 | 6.30 | 5.72 | 5.81 | 5.28 | 4.86 | 4.56 | 4.24 | 4.16 | 3.95 | 3.82 | 3.25 | 4.22 | |
| Operating Income | 3.97 | 3.97 | 2.64 | 2.34 | 1.65 | 2.04 | 1.04 | 1.52 | 1.51 | 1.29 | 0.45 | -0.33 | 0.30 | 0.12 | -3.87 | 0.90 | -0.66 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.36 | 0.36 | ||
| Selling General & Admin Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.38 | 1.24 | ||
| Depreciation & Amortization | 0.00 | 0.34 | 0.34 | 0.33 | 0.35 | 0.31 | 0.31 | 0.30 | 0.31 | 0.30 | ||
| Total Operating Expenses | 2.73 | 2.49 | 2.61 | 2.05 | 2.08 | 1.97 | 1.84 | 1.74 | 1.96 | 1.81 | ||
| Operating Income | 1.21 | 1.05 | 0.82 | 0.90 | 0.59 | 0.67 | 0.75 | 0.64 | 0.58 | 0.69 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.00 | 0.00 | 0.11 | 0.02 | 0.01 | 0.00 | 0.00 | 0.03 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | |
| Interest Expense | 0.35 | 0.35 | 0.39 | 0.27 | 0.47 | 0.34 | 0.36 | 0.47 | 0.24 | 0.23 | 0.23 | 0.28 | 0.22 | 0.32 | 0.26 | 0.28 | 0.39 | |
| Other Expense | -0.59 | -0.59 | -0.35 | -0.36 | -0.51 | -0.97 | -1.18 | -0.83 | 0.00 | -0.37 | -0.91 | -1.36 | -0.60 | -0.78 | -4.78 | -0.79 | -1.66 | |
| IBT | 3.39 | 3.39 | 2.28 | 1.99 | 1.14 | 1.08 | -0.14 | 0.69 | 1.42 | 0.93 | 0.18 | -0.65 | 0.09 | -0.22 | -4.11 | 0.64 | -1.06 | |
| Income Tax Expense | 0.49 | 0.49 | 0.44 | 0.39 | 0.44 | 0.04 | 0.00 | -4.01 | -0.25 | 0.83 | -0.17 | -0.41 | -0.18 | -0.10 | -0.04 | 0.20 | 0.00 | |
| Net Income | 2.89 | 2.89 | 1.85 | 1.59 | 0.70 | 1.04 | -0.14 | 4.70 | 1.67 | 0.10 | 0.35 | -0.24 | 0.27 | -0.12 | -4.07 | 0.44 | -1.07 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.02 | 0.07 | ||
| Interest Expense | 0.09 | 0.09 | 0.09 | 0.09 | 0.14 | 0.08 | 0.08 | 0.07 | 0.07 | 0.07 | ||
| Other Expense | -0.51 | -0.11 | 0.12 | -0.09 | 0.00 | -0.01 | -0.33 | -0.04 | -0.08 | -0.08 | ||
| IBT | 0.70 | 0.94 | 0.94 | 0.81 | 0.59 | 0.67 | 0.42 | 0.61 | 0.51 | 0.61 | ||
| Income Tax Expense | 0.03 | 0.18 | 0.15 | 0.13 | 0.02 | 0.20 | 0.10 | 0.12 | 0.00 | 0.11 | ||
| Net Income | 0.67 | 0.76 | 0.79 | 0.67 | 0.57 | 0.47 | 0.32 | 0.49 | 0.51 | 0.50 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $1.08 | $0.49 | $0.69 | $-0.10 | $3.38 | $1.21 | $0.08 | $0.26 | $-0.18 | $0.20 | $-0.09 | $-2.89 | $0.29 | $-0.70 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $1.07 | $0.49 | $0.69 | $-0.10 | $3.33 | $1.19 | $0.08 | $0.25 | $-0.18 | $0.20 | $-0.09 | $-2.89 | $0.29 | $-0.70 | |
| Shares Outstanding | 1.48 | 1.48 | 1.47 | 1.45 | 1.43 | 1.42 | 1.42 | 1.39 | 1.38 | 1.37 | 1.36 | 1.34 | 1.32 | 1.34 | 1.41 | 1.51 | 1.52 | |
| Diluted Shares Outstanding | 1.50 | 1.49 | 1.49 | 1.46 | 1.44 | 1.43 | 1.42 | 1.41 | 1.40 | 1.39 | 1.38 | 1.34 | 1.35 | 1.34 | 1.41 | 1.52 | 1.52 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.34 | $0.34 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.34 | $0.34 | ||
| Shares Outstanding | 1.48 | 1.48 | 1.48 | 1.48 | 1.47 | 1.47 | 1.47 | 1.47 | 1.47 | 1.46 | ||
| Diluted Shares Outstanding | 1.50 | 1.50 | 1.49 | 1.49 | 1.49 | 1.49 | 1.48 | 1.48 | 1.48 | 1.48 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 2.99 | 0.41 | 0.87 | 0.93 | 1.93 | 1.73 | 0.22 | 0.15 | 0.19 | 0.20 | 0.32 | 0.59 | 0.22 | 0.21 | 0.27 | 0.21 | |
| Short Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Cash & ST Investments | 2.99 | 0.41 | 0.87 | 0.93 | 1.93 | 1.73 | 0.22 | 0.15 | 0.19 | 0.20 | 0.32 | 0.59 | 0.22 | 0.21 | 0.27 | 0.21 | |
| Accounts Receivable | 2.40 | 2.56 | 2.23 | 1.97 | 1.78 | 1.53 | 1.93 | 1.61 | 1.55 | 1.47 | 1.28 | 1.18 | 1.31 | 1.22 | 1.25 | 1.32 | |
| Inventory | 2.61 | 2.81 | 2.48 | 1.87 | 1.61 | 1.35 | 1.58 | 1.17 | 1.08 | 0.96 | 1.02 | 0.95 | 0.90 | 0.88 | 0.93 | 0.89 | |
| Other Current Assets | 1.00 | 1.14 | 0.94 | 0.35 | 0.39 | 0.41 | 0.32 | 0.92 | 0.94 | 0.54 | 0.37 | 0.44 | 0.30 | 0.28 | 0.66 | 0.58 | |
| Total Current Assets | 8.99 | 6.92 | 6.51 | 5.76 | 6.32 | 6.69 | 4.70 | 4.00 | 3.82 | 3.24 | 3.47 | 3.39 | 3.17 | 3.02 | 3.11 | 3.62 |
| Current Assets | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 0.53 | 0.73 | 0.41 | 2.50 | 2.91 | 2.33 | 0.87 | 0.95 | 0.43 | 0.57 | |
| Short Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Cash & ST Investments | 0.53 | 0.73 | 0.41 | 2.50 | 2.91 | 2.33 | 0.87 | 0.95 | 0.43 | 0.57 | |
| Accounts Receivable | 2.82 | 2.69 | 2.56 | 2.50 | 2.40 | 2.30 | 2.23 | 2.10 | 2.13 | 2.08 | |
| Inventory | 2.86 | 2.87 | 2.81 | 2.75 | 2.61 | 2.56 | 2.48 | 2.40 | 2.25 | 2.05 | |
| Other Current Assets | 0.91 | 1.05 | 1.14 | 1.01 | 1.07 | 0.99 | 0.94 | 1.05 | 1.08 | 1.01 | |
| Total Current Assets | 7.12 | 7.34 | 6.92 | 8.76 | 8.99 | 8.19 | 6.51 | 6.50 | 5.89 | 5.70 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 3.37 | 3.74 | 3.30 | 2.83 | 2.69 | 2.54 | 2.42 | 1.78 | 1.70 | 1.63 | 1.49 | 1.51 | 1.55 | 1.56 | 1.67 | 1.70 | |
| Goodwill | 14.40 | 17.09 | 14.39 | 12.92 | 11.99 | 9.95 | 10.18 | 7.91 | 7.00 | 6.68 | 6.47 | 5.90 | 5.69 | 5.97 | 9.76 | 10.19 | |
| Intangible Assets | 5.42 | 6.68 | 6.00 | 5.90 | 6.12 | 5.92 | 7.89 | 6.37 | 5.84 | 5.88 | 6.19 | 5.61 | 5.95 | 6.29 | 6.47 | 6.34 | |
| Long-Term Investments | 0.59 | 0.56 | 0.41 | 0.41 | 0.41 | 0.92 | 0.46 | -0.33 | -0.19 | -0.08 | -0.50 | -0.45 | -0.29 | -0.43 | -0.46 | -0.43 | |
| Other Long-Term Assets | 0.55 | 0.75 | 0.68 | 0.71 | 0.56 | 0.55 | 0.74 | 0.93 | 0.69 | 0.67 | 0.51 | 0.43 | 0.37 | 0.31 | 0.28 | 0.29 | |
| Total Long-Term Assets | 28.12 | 32.48 | 28.62 | 26.71 | 25.91 | 24.08 | 25.87 | 17.00 | 15.22 | 14.86 | 14.66 | 13.44 | 13.56 | 14.13 | 18.19 | 18.51 | |
| Total Assets | 37.11 | 39.40 | 35.14 | 32.47 | 32.23 | 30.78 | 30.57 | 21.00 | 19.04 | 18.10 | 18.13 | 16.83 | 16.73 | 17.15 | 21.29 | 22.13 |
| Long-Term Assets | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 3.95 | 3.84 | 3.74 | 3.50 | 3.37 | 3.33 | 3.30 | 3.08 | 2.98 | 2.88 | |
| Goodwill | 18.08 | 17.34 | 17.09 | 15.03 | 14.40 | 14.36 | 14.39 | 13.61 | 13.66 | 13.27 | |
| Intangible Assets | 7.26 | 6.57 | 6.68 | 5.75 | 5.42 | 5.84 | 6.00 | 5.85 | 6.06 | 6.06 | |
| Long-Term Investments | 0.63 | 0.66 | 0.56 | 0.53 | 0.59 | 0.43 | 0.41 | 0.43 | 0.42 | 0.39 | |
| Other Long-Term Assets | 0.75 | 0.73 | 0.75 | 0.68 | 0.55 | 0.74 | 0.68 | 0.73 | 0.73 | 0.70 | |
| Total Long-Term Assets | 34.44 | 32.81 | 32.48 | 29.32 | 28.12 | 28.48 | 28.62 | 27.54 | 27.72 | 27.19 | |
| Total Assets | 41.56 | 40.14 | 39.40 | 38.08 | 37.11 | 36.67 | 35.14 | 34.04 | 33.60 | 32.89 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 0.91 | 0.96 | 0.94 | 0.86 | 0.79 | 0.51 | 0.54 | 0.35 | 0.53 | 0.45 | 0.21 | 0.26 | 0.25 | 0.23 | 0.20 | 0.18 | |
| Short-Term Debt | 1.58 | 1.78 | 0.53 | 0.02 | 0.26 | 0.01 | 1.42 | 2.25 | 1.80 | 0.06 | 0.00 | 0.40 | 0.00 | 0.00 | 0.00 | 0.50 | |
| Other Current Liabilities | 2.81 | 3.05 | 2.97 | 2.70 | 3.01 | 3.02 | 2.76 | 2.33 | 3.13 | 3.00 | 1.72 | 1.13 | 1.29 | 1.10 | 1.14 | 1.49 | |
| Current Liabilities | 5.58 | 6.40 | 4.93 | 3.80 | 4.27 | 3.68 | 4.87 | 5.26 | 5.65 | 3.59 | 2.43 | 2.25 | 1.82 | 1.77 | 1.81 | 2.61 |
| Current Liabilities | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 0.96 | 1.00 | 0.96 | 0.91 | 0.91 | 0.92 | 0.94 | 0.93 | 0.90 | 0.87 | |
| Short-Term Debt | 0.48 | 0.78 | 1.78 | 1.65 | 1.58 | 1.09 | 0.53 | 0.51 | 0.56 | 0.51 | |
| Other Current Liabilities | 3.26 | 2.68 | 3.09 | 2.73 | 2.58 | 2.37 | 2.97 | 2.54 | 2.46 | 2.19 | |
| Current Liabilities | 5.19 | 5.06 | 6.40 | 5.91 | 5.58 | 4.92 | 4.93 | 4.58 | 4.56 | 4.08 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 8.99 | 9.37 | 8.96 | 9.26 | 9.19 | 9.53 | 8.86 | 4.78 | 3.78 | 5.42 | 5.67 | 3.86 | 4.24 | 4.25 | 4.26 | 4.93 | |
| Capital Leases | 0.37 | 0.53 | 0.40 | 0.35 | 0.40 | 0.41 | 0.28 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Def. Tax Liability | 0.13 | 0.16 | 0.13 | 0.14 | 0.31 | 0.33 | 0.60 | 0.33 | 0.19 | 0.02 | 0.74 | 1.22 | 1.56 | 1.73 | 1.87 | 1.64 | |
| Total Liabilities | 16.50 | 17.39 | 15.61 | 14.90 | 15.61 | 15.45 | 16.69 | 12.27 | 12.03 | 11.36 | 11.81 | 9.99 | 10.20 | 10.28 | 9.94 | 10.83 |
| Long-Term Liabilities | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 11.55 | 10.93 | 9.37 | 9.61 | 9.36 | 9.92 | 8.96 | 8.79 | 8.90 | 8.86 | |
| Capital Leases | 0.57 | 0.53 | 0.53 | 0.38 | 0.37 | 0.39 | 0.40 | 0.40 | 0.41 | 0.37 | |
| Def. Tax Liability | 0.23 | 0.16 | 0.16 | 0.14 | 0.13 | 0.13 | 0.13 | 0.09 | 0.14 | 0.21 | |
| Total Liabilities | 18.91 | 17.69 | 17.39 | 17.12 | 16.50 | 16.50 | 15.61 | 14.91 | 15.12 | 14.78 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Retained Earnings | 1.64 | 2.67 | 0.82 | -0.75 | -1.39 | -2.38 | -2.25 | -6.95 | -8.39 | -8.58 | -8.93 | -8.30 | -8.57 | -8.48 | -4.38 | -4.82 | |
| Comprehensive Income | 0.16 | 0.28 | 0.05 | 0.27 | 0.26 | 0.21 | 0.27 | 0.03 | -0.06 | 0.00 | 0.09 | 0.14 | 0.11 | -0.03 | -0.14 | -0.13 | |
| Total Common Equity | 20.37 | 21.77 | 19.28 | 17.57 | 16.62 | 15.33 | 13.88 | 8.73 | 7.01 | 6.73 | 6.32 | 6.84 | 6.54 | 6.87 | 11.35 | 11.30 |
| Total Common Equity | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Retained Earnings | 4.14 | 3.35 | 2.67 | 2.11 | 1.64 | 1.31 | 0.82 | 0.32 | -0.19 | -0.45 | |
| Comprehensive Income | -0.72 | -0.03 | 0.28 | -0.13 | 0.16 | 0.13 | 0.05 | 0.23 | 0.21 | 0.18 | |
| Total Common Equity | 22.42 | 22.21 | 21.77 | 20.71 | 20.37 | 19.93 | 19.28 | 18.89 | 18.23 | 17.85 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 10.94 | 11.15 | 9.49 | 9.28 | 9.45 | 9.54 | 10.28 | 7.03 | 5.58 | 5.48 | 5.68 | 4.26 | 4.24 | 4.26 | 4.26 | 5.44 | |
| Book Value | 20.61 | 22.00 | 19.53 | 17.57 | 16.62 | 15.33 | 13.88 | 8.73 | 7.01 | 6.73 | 6.32 | 6.84 | 6.54 | 6.87 | 11.35 | 11.30 |
| Other | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | 1-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.24 | 0.23 | 0.23 | 0.25 | 0.24 | 0.24 | 0.25 | 0.24 | 0.26 | 0.26 | |
| Book Value | 22.42 | 22.21 | 21.77 | 20.71 | 20.37 | 19.93 | 19.28 | 18.89 | 18.23 | 17.85 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 1.83 | 2.89 | 1.85 | 1.59 | 0.70 | 1.04 | -0.08 | 4.70 | 1.67 | 0.10 | 0.35 | -0.24 | -0.12 | -0.12 | -4.07 | 0.44 | -1.07 | |
| Depreciation & Amortization | 1.23 | 1.37 | 1.27 | 1.20 | 1.14 | 1.09 | 1.12 | 1.01 | 0.89 | 0.84 | 0.82 | 0.77 | 0.73 | 0.69 | 0.68 | 0.72 | 0.82 | |
| Stock-Based Compensation | 0.38 | 0.30 | 0.27 | 0.23 | 0.22 | 0.19 | 0.17 | 0.16 | 0.14 | 0.13 | 0.12 | 0.11 | 0.10 | 0.11 | 0.11 | 0.13 | 0.15 | |
| Change Working Capital | -1.19 | -0.25 | -0.46 | -0.77 | -1.01 | -0.35 | 0.04 | -0.28 | -2.16 | 0.07 | 0.00 | 0.28 | 0.96 | 0.16 | 0.28 | -0.24 | -1.37 | |
| Change In Accounts Receivable | -0.31 | -0.27 | -0.35 | -0.24 | -0.22 | -0.28 | 0.34 | -0.13 | -0.11 | -0.03 | -0.22 | -0.02 | 0.05 | -0.10 | 0.04 | 0.04 | 0.05 | |
| Change In Accounts Payable | -0.34 | 0.30 | 0.24 | 0.12 | -0.26 | 0.41 | 0.09 | 0.11 | -0.71 | 0.20 | 0.55 | -0.02 | 0.62 | -0.04 | -0.13 | -0.27 | -1.15 | |
| Change In Inventories | -0.48 | -0.19 | -0.23 | -0.66 | -0.32 | -0.35 | -0.07 | -0.29 | -0.08 | -0.11 | 0.04 | 0.00 | -0.08 | -0.01 | 0.07 | -0.05 | -0.01 | |
| Other Non-cash Items | 1.28 | 0.22 | 0.52 | 0.25 | 0.54 | 0.02 | 0.34 | 0.55 | -0.15 | 0.04 | 0.00 | 0.22 | -0.01 | 0.48 | 4.42 | -0.09 | 1.91 | |
| Cash from Operations | 2.63 | 0.00 | 0.00 | 2.50 | 1.53 | 1.87 | 1.51 | 1.84 | 0.31 | 1.43 | 0.97 | 0.60 | 1.27 | 1.08 | 1.26 | 1.01 | 0.33 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 0.67 | 0.76 | 0.80 | 0.67 | 0.56 | 0.70 | 0.32 | 0.49 | 0.50 | 0.50 | |
| Depreciation & Amortization | 0.37 | 0.34 | 0.34 | 0.33 | 0.35 | 0.64 | 0.31 | 0.30 | 0.31 | 0.30 | |
| Stock-Based Compensation | 0.00 | 0.08 | 0.08 | 0.07 | 0.07 | -0.06 | 0.20 | 0.06 | 0.06 | 0.06 | |
| Change Working Capital | 0.16 | 0.04 | 0.23 | -0.68 | 0.32 | 0.17 | -0.21 | -0.74 | -0.06 | -0.18 | |
| Change In Accounts Receivable | -0.10 | -0.03 | -0.03 | -0.11 | 0.05 | -0.03 | -0.11 | -0.11 | -0.07 | 0.00 | |
| Change In Accounts Payable | 0.29 | 0.17 | 0.23 | -0.39 | 0.39 | 0.24 | 0.07 | -0.45 | 0.02 | 0.02 | |
| Change In Inventories | -0.05 | -0.09 | 0.07 | -0.11 | 0.05 | -0.06 | -0.10 | -0.12 | -0.06 | -0.20 | |
| Other Non-cash Items | 0.19 | 0.05 | -0.06 | 0.11 | 0.23 | -0.43 | 0.20 | 0.02 | 0.07 | 0.04 | |
| Cash from Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.96 | 0.70 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.87 | -0.88 | -0.79 | -0.71 | -0.61 | -0.55 | -0.38 | -0.46 | -0.32 | -0.32 | -0.38 | -0.25 | -0.26 | -0.25 | -0.23 | -0.30 | -0.28 | |
| Acquisitions | -0.89 | -1.59 | -4.64 | -1.81 | -1.54 | -1.43 | 0.01 | -4.29 | -1.45 | -0.56 | -0.41 | -1.73 | -0.47 | -0.24 | -0.36 | 1.06 | -0.21 | |
| Investments | -0.18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | -0.15 | -0.35 | -0.17 | -0.13 | -0.13 | -0.27 | -0.03 | -0.04 | -0.02 | -0.01 | 0.01 | |
| Sales of Investment | 0.04 | 0.00 | 0.00 | 0.00 | 0.06 | 0.29 | 0.01 | 0.06 | 0.01 | 0.13 | 0.00 | 0.06 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | |
| Other Investing Activities | 0.02 | 0.00 | 0.00 | -0.05 | 0.08 | 0.00 | 0.09 | 0.00 | 0.00 | -0.13 | 0.03 | 0.00 | 0.00 | 0.05 | 0.02 | 0.02 | 0.00 | |
| Cash from Investing | -1.81 | 0.00 | 0.00 | -2.57 | -2.01 | -1.60 | -0.41 | -5.04 | -1.92 | -1.01 | -0.89 | -2.19 | -0.75 | -0.48 | -0.58 | 0.77 | -0.48 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.35 | -0.18 | -0.16 | -0.19 | -0.28 | -0.18 | -0.16 | -0.18 | -0.27 | -0.21 | |
| Acquisitions | -0.09 | -0.26 | -1.01 | -0.24 | -3.42 | -1.13 | -0.05 | -0.05 | -0.79 | 0.00 | |
| Investments | -0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.07 | -0.07 | -0.03 | -0.02 | |
| Sales of Investment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.02 | |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | |
| Cash from Investing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.05 | -0.20 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -1.66 | 0.00 | 0.00 | 0.00 | -3.44 | 0.00 | -6.84 | -4.56 | -1.17 | -3.22 | -0.82 | -1.72 | -0.81 | -1.79 | -0.39 | -1.82 | -1.70 | |
| Debt Issued | 3.14 | 11.15 | 1.66 | 0.21 | 3.27 | -0.09 | 6.11 | 7.81 | 2.62 | 3.31 | 0.63 | 3.13 | 0.83 | 1.77 | 0.39 | 0.64 | 7.14 | |
| Issuance of Common Stock | 0.20 | 0.00 | 0.00 | 0.18 | 0.00 | 0.00 | 0.98 | 0.12 | 0.10 | 0.09 | 0.11 | 0.11 | 0.06 | 0.07 | 0.02 | 0.02 | 0.03 | |
| Repurchase of Common Stock | 0.20 | 0.00 | 0.00 | 0.18 | 0.14 | 0.11 | -0.54 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.13 | -0.50 | -0.60 | -0.49 | 0.00 | |
| Dividends Paid | 0.00 | 0.00 | 0.00 | -0.03 | -0.06 | -0.06 | -0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.76 | -1.78 | -0.37 | 0.00 | 0.00 | |
| Other Financing Activities | -0.02 | 0.00 | 0.00 | 0.04 | 2.81 | -0.15 | 6.72 | 7.41 | 2.50 | 3.24 | 0.50 | 2.92 | 1.48 | 3.40 | 0.60 | 0.57 | 1.17 | |
| Cash from Financing | 1.62 | 0.00 | 0.00 | 0.01 | -0.55 | -0.10 | 0.29 | 2.97 | 1.43 | 0.11 | -0.21 | 1.32 | -0.15 | -0.60 | -0.74 | -1.72 | -0.50 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.04 | |
| Debt Issued | 0.00 | 12.03 | 0.32 | 0.56 | -0.11 | 0.32 | -0.07 | 1.51 | 0.19 | -0.11 | |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.08 | |
| Repurchase of Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 | 0.12 | 0.00 | |
| Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.06 | |
| Cash from Financing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 2.44 | 1.54 | -0.45 | -0.07 | -1.04 | 0.17 | 1.39 | -0.22 | -0.19 | 0.53 | -0.12 | -0.27 | 0.37 | 0.01 | -0.06 | 0.05 | -0.65 | |
| Closing Cash Balance | 2.99 | 2.15 | 0.61 | 1.06 | 1.13 | 2.17 | 2.00 | 0.61 | 0.83 | 1.02 | 0.20 | 0.32 | 0.59 | 0.22 | 0.21 | 0.27 | 0.21 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 0.67 | 0.73 | -0.18 | 0.31 | -2.04 | -0.41 | 0.57 | 1.44 | -0.08 | 0.51 | |
| Closing Cash Balance | 2.05 | 1.37 | 0.74 | 0.92 | 0.61 | 2.65 | 2.99 | 2.50 | 1.06 | 1.13 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 1.76 | 3.66 | 2.65 | 1.70 | 0.91 | 1.32 | 1.13 | 1.38 | -0.01 | 1.11 | 0.60 | 0.35 | 1.01 | 0.84 | 1.03 | 0.70 | 0.05 | |
| Real Free Cash Flow | 1.38 | 3.36 | 2.38 | 1.47 | 0.69 | 1.12 | 0.96 | 1.22 | -0.15 | 0.98 | 0.48 | 0.25 | 0.91 | 0.73 | 0.93 | 0.58 | -0.10 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 1.01 | 1.16 | 1.10 | 0.35 | 1.16 | 0.70 | 0.66 | -0.08 | 0.69 | 0.49 | |
| Real Free Cash Flow | 1.01 | 1.08 | 1.02 | 0.28 | 1.09 | 0.76 | 0.46 | -0.14 | 0.63 | 0.43 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 36 | -5 | 179.3 |
| P/S | 5.2 | 4.2 | 390.6 |
| P/B | 4.6 | 3.8 | 113.4 |
| P/FCF | 30.6 | 2.1 | 149.9 |
| Market cap | $148.2 | $98.4 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 27.8 % | 0 % |
| Debt to Income | 416.2 % | -476.8 % | 0 % |
| Debt to Free cash flow | 354 % | 10.9 % | 0 % |
| Interest expense percentage | 8.9 % | 50.1 % | 11.2 % |
| Current ratio | 1.4 | 1.4 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 12.9 % | 1.4 % | 0 % |
| ROA | 7 % | 0.9 % | 0 % |
| CapEx to Revenue | 4.4 % | 3.9 % | 6 % |
| RaD to Revenue | 0 % | 10.8 % | 0 % |
| ROEM | 378,773.6 | 255826.6 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 69 % | 68.2 % | 61.9 % |
| Operating margin | 19.8 % | 3.2 % | 17.9 % |
| Net margin | 14.4 % | 1.7 % | 13 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 1 % | 0 % |
| Dividend payout percentage | 0 % | -69.5 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 1,495.8 mil | 1,425.5 mil |
| Employee count | 53.0 tis | 25.6 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
